Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01943422
Title Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma
Acronym 12-107
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors John Kirkwood
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST